These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11867025)

  • 21. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients.
    Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A
    Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strains of ganciclovir-resistant cytomegalovirus].
    Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I
    Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
    Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
    J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
    Chong PP; Teiber D; Prokesch BC; Arasaratnam RJ; Peltz M; Drazner MH; Garg S
    Transpl Infect Dis; 2018 Oct; 20(5):e12965. PubMed ID: 29989279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
    Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
    J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
    Reusser P; Hostettler B; Attehbofer R
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir.
    Strasfeld L; Lee I; Tatarowicz W; Villano S; Chou S
    J Infect Dis; 2010 Jul; 202(1):104-8. PubMed ID: 20504236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation.
    Hazar V; Kansoy S; Küpesiz A; Aksoylar S; Kantar M; Yeşilipek A
    Bone Marrow Transplant; 2004 May; 33(9):931-5. PubMed ID: 15034541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.
    Verkruyse LA; Storch GA; Devine SM; Dipersio JF; Vij R
    Bone Marrow Transplant; 2006 Jan; 37(1):51-6. PubMed ID: 16284613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
    Casillo R; Grimaldi M; Ragone E; Maiello C; Marra C; De Santo L; Amarelli C; Romano G; Della Corte A; Portella G; Tripodi MF; Fortunato R; Cotrufo M; Utili R
    Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
    Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M
    Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
    Fica A; Cervera C; Pérez N; Marcos MA; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Pumarola T; Moreno A
    Transpl Infect Dis; 2007 Sep; 9(3):203-10. PubMed ID: 17511827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.